close

National Comprehensive Cancer Network

National Comprehensive Cancer Network

Immunotherapy Takes Center Stage in NCCN Advanced Melanoma Guideline

 

The revised guideline (Version 2.2016) for the management of advanced melanoma, released by the National Comprehensive Cancer Network (NCCN), shows increasing appreciation for the use of immune checkpoint inhibitors and [ Read More ]

National Comprehensive Cancer Network

New MM Guideline Expands Patients Eligible for Treatment

 

The population of patients with multiple myeloma (MM) who are eligible for therapy has been expanded to asymptomatic patients with certain features under the most recent National Comprehensive Cancer Network [ Read More ]

National Comprehensive Cancer Network

Panel Examines Effects of Healthcare Policy in an Election Year

 

The chances for further policy in healthcare during an election year are minimal, said panelists during a roundtable discussion at the National Comprehensive Cancer Network 21st Annual Conference. The exception [ Read More ]

National Comprehensive Cancer Network

Test for EGFR Mutation in All Patients with NSCLC

Matching Treatment to Molecular Alteration Yields Best Outcomes

 

Tyrosine kinase inhibitors (TKIs) are the mainstay of treatment for patients with EGFR mutation–positive non–small cell lung cancer (NSCLC), according to the most recent guideline on management of NSCLC issued [ Read More ]